Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-02-26Clinical Trial Update: Women Surviving Ovarian Cancer
This Clinical Trial Update notes the completed status of a study focused on survivorship and quality of life in women with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment [Phase 1]
Phase 1 study evaluating the safety and tolerability of CRS-207, a live-attenuated Listeria monocytogenes-based cancer vaccine, in adults wi…
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies [Phase 3]
This is a Phase 3 clinical trial update examining preoperative psychological intervention to reduce stress in women with gynecological cance…
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer [Phase 2]
Phase 2 trial evaluating pegfilgrastim with a multi-day topotecan regimen in relapsed or refractory ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group [Phase 2, Phase 3]
Completed phase 2/3 trial of Removab (catumaxomab) in EpCAM-positive patients with symptomatic malignant ascites, comparing with an untreate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-23Clinical Trial Update: Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies [Phase 1]
This update describes a Phase 1 study evaluating topotecan in combination with pemetrexed in patients with advanced ovarian, endometrial, ce…
-
CLINICAL_TRIALS trial_result · 2008-11-25Clinical Trial Update: Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 safety and efficacy study of Panzem Nanocrystal Colloidal Dispersion in patie…
-
FDA approval · 2008-11-07FDA Approved: ETHYOL — Supplemental Application (Legacy Pharma USA Inc.)
The FDA approved a supplemental application for ETHYOL (amifostine) submitted by Legacy Pharma USA Inc.
-
CLINICAL_TRIALS trial_result · 2008-11-07Clinical Trial Update: A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 study of D4064A for recurrent/persistent epithelial ovarian, primary peritoneal, or fallopian tube cancer is currently suspended.
-
CLINICAL_TRIALS research · 2008-10-15Clinical Trial Update: A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer [Phase 2]
A Phase I/II clinical trial evaluating the combination of paclitaxel, carboplatin, and vorinostat in patients with recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2008-09-22Clinical Trial Update: Phase II CT-2103/Carboplatin in Ovarian Cancer [Phase 2]
Phase II trial of CT-2103 in combination with carboplatin for ovarian cancer has completed.
-
FDA approval · 2008-09-05FDA Approved: HYCAMTIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Hycamtin (topotecan) submitted by Sandoz Inc.
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of docetaxel and oxaliplatin in patients with stage III or IV ovarian cancer (epitheli…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: A Phase I Study of ECO-4601 in Patients With Advanced Cancer [Phase 1]
Phase I study of ECO-4601 in patients with advanced cancer has completed.
-
CLINICAL_TRIALS research · 2008-07-15Clinical Trial Update: Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study [Phase 3]
A Phase III randomized trial evaluating neoadjuvant chemotherapy for advanced epithelial ovarian cancer is described. The current study stat…
-
CLINICAL_TRIALS research · 2008-06-30Clinical Trial Update: Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
This clinical trial update describes a tissue bank study collecting biological specimens from patients with gynecologic diseases, including …
-
CLINICAL_TRIALS research · 2008-06-30Clinical Trial Update: Questionnaire Study for Gynecological Cancer Survivors
This document describes a questionnaire study for gynecological cancer survivors, with the trial status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Assess Cancer in Ovarian Tumors With Biomarkers. [NA]
A biomarker-based clinical trial assessing cancer in ovarian tumors sponsored by Ciphergen Biosystems has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-09Clinical Trial Update: Examining the Long-Term Risks of Oophorectomy
This completed trial update analyzes long-term health risks after oophorectomy, including coronary heart disease, stroke, breast cancer, ova…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin [Phase 2]
Phase II results of a 72-hour continuous intravenous infusion of 9-aminocamptothecin with G-CSF support in patients with advanced ovarian ca…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 [Phase 1]
A Phase I trial studying infusional chemotherapy with the P-glycoprotein antagonist PSC 833 has been completed in patients with several canc…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Outcomes of Education and Counseling for BRCA1 Testing
A completed clinical trial assessing the outcomes of education and counseling for BRCA1 genetic testing.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients [Phase 1]
Phase I study evaluating a four-drug regimen of paclitaxel (Taxol), cisplatin, cyclophosphamide, and G-CSF in previously untreated ovarian c…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 [Phase 1]
Phase I study of infusional paclitaxel combined with the P-glycoprotein antagonist PSC 833 (valspodar) in patients with various cancers; the…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: SU5416 and Carboplatin to Treat Ovarian Cancer [Phase 1]
A Phase 1 study evaluated SU5416 in combination with carboplatin for ovarian, fallopian tube, and peritoneal cancers; the trial status shows…